In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-5 of 5 for your search:
Drug:  liposome-encapsulated irinotecan hydrochloride PEP02
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MM-398-07-03-01, NCT01494506

2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PEP0206, EudraCT number: 2006-006452-35, NCT00813072

3.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PEP0208, NCT00813163

4.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000701454, FRE-GERCOR-PEPCOL-C10-1, EU-21115, EUDRACT-2010-020468-39, PHARMAENGINE-FRE-GERCOR-PEPCOL, GERCOR-PEPCOL C10-1, PEPCOL, PHARMAENGINE-FRE-GERCOR-PEPCOL-C10-1, NCT01375816

5.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PIST-CRC-01, NCT00940758
New Search